Company Spotlight

Biosynth Carbosynth

4 Rietlistrasse,
Staad, SG 9422
Switzerland
View Profile


Contract Service Directory


Samyang Biopharmaceuticals





Company Headquarters


295
성남시, 경기도 South Korea

Contract Service Directory

    Related Content

    • Breaking News | cGMP Manufacture | Fill/Finish | Industry News
      GRAM Attains EU GMP Certification for Commercial Aseptic Fill/Finish

      GRAM Attains EU GMP Certification for Commercial Aseptic Fill/Finish

      Recognizes manufacturing facility and processes are in compliance with GMP requirements and readiness to provide commercial aseptic fill/finish services.
      Kristin Brooks 03.30.21

    • Breaking News | Industry News | Promotions & Moves
      Sharp Appoints EU Qualified Person

      Sharp Appoints EU Qualified Person

      Names Ria Rhemrev-Boom as its new lead EU Qualified Person (QP) for market release services.
      Tim Wright, Editor, Contract Pharma 03.09.21

    • Aseptic Processing | Fill/Finish
      A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility

      A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility

      Overcoming today’s aseptic fill-and-finish process challenges.
      Ute Schleyer, Project Manager, Site & Plant Development, Vetter 10.14.20


    • Bio News | Breaking News | Facilities | Industry News
      CellGenix Expands Facility

      CellGenix Expands Facility

      Meets the growing demand for GMP raw materials.
      Contract Pharma Staff 10.13.20

    • Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
      Swiss American CDMO Expands in Texas

      Swiss American CDMO Expands in Texas

      Adds new 131,760 square-foot industrial facility.
      Contract Pharma Staff 09.03.20

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      Mapp Biopharma Partners with CDMO Avid Bioservices

      Mapp Biopharma Partners with CDMO Avid Bioservices

      For clinical development of novel human monoclonal antiviral antibody.
      Contract Pharma Staff 08.26.20


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      CDMO Ology Bioservices Gets $106.3M U.S. Army Contract

      CDMO Ology Bioservices Gets $106.3M U.S. Army Contract

      To reserve production capacity in support of Operation Warp Speed.
      Contract Pharma Staff 08.26.20

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Maravai LifeSciences Expands CDMO Capabilities at TriLink

      Maravai LifeSciences Expands CDMO Capabilities at TriLink

      To increase small molecule manufacturing capacity for additional scale-up of CleanCap messenger RNA capping technology for vaccine and therapeutic programs.
      Contract Pharma Staff 08.25.20

    • Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
      AGC Biologics Enters CDMO Partnership with Ono Pharmaceuticals

      AGC Biologics Enters CDMO Partnership with Ono Pharmaceuticals

      To manufacture biopharmaceuticals at clinical development stage.
      Contract Pharma Staff 08.20.20


    • Breaking News | Industry News
      Swiss American CDMO Appears In 2020 Inc. 5000 List

      Swiss American CDMO Appears In 2020 Inc. 5000 List

      Named one of the fastest-growing private companies in America.
      Contract Pharma Staff 08.18.20

    • Breaking News | Facilities | Industry News | R&D
      CDMO Sai Life Sciences Opens New Facility

      CDMO Sai Life Sciences Opens New Facility

      State-of-the-art research and technology center is located in Hyderabad, India and completes first phase in $150 million investment.
      Contract Pharma Staff 08.18.20

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Beroni Signs Agreement with CDMO Genscript Biotech

      Beroni Signs Agreement with CDMO Genscript Biotech

      To conduct further study to develop nanobody-based medical solution for COVID-19.
      Contract Pharma Staff 08.12.20


    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Sekisui Diagnostics Invests in Biopharma CDMO Capacity

      Sekisui Diagnostics Invests in Biopharma CDMO Capacity

      Investing £14.4 million in its biopharma CDMO business aimed at cGMP microbial capacity expansion at its site in Maidstone, Kent.
      Contract Pharma Staff 08.04.20

    • Bio News | Breaking News | Collaborations & Alliances | Industry News
      Altimmune and CDMO Vigene Enter COVID-19 Vax Pact

      Altimmune and CDMO Vigene Enter COVID-19 Vax Pact

      Ink manufacturing agreement for AdCOVID single dose intranasal vaccine candidate.
      Contract Pharma Staff 08.03.20

    • Breaking News | cGMP Manufacture
      Sekisui Invests $18.93 Million in Biopharma CDMO Business

      Sekisui Invests $18.93 Million in Biopharma CDMO Business

      Expands cGMP microbial capacity in Maidstone, Kent site.
      Contract Pharma Staff 07.31.20

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      GenScript Expands CDMO Capabilities

      GenScript Expands CDMO Capabilities

      Launches CDMO segment "GenScript ProBio" dedicated to providing services from discovery to commercialization.
      Contract Pharma Staff 07.23.20